𝔖 Bobbio Scriptorium

✦ LIBER ✦

1085 Multicenter international randomized study of oxaliplatin/5FU/LV (folfox) in stage II and III colon cancer (mosaic trial): final results

✍ Scribed by Topham, C.; Boni, C.; Navarro, M.; Hickish, T.; Tabernero, J.; Bonetti, A.; Andre, T.; de Gramont, A.

Book ID: 122555023
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 324 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(03)91111-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial of 5-Fluorouracil (5-FU

Randomized trial of 5-Fluorouracil (5-FU)-Levamisol (LEV) versus 5FU-LEV-Leucovorin (LV) in patients with colorrectal cancer stage II and III. Eigth years results

✍ A. Murias; J. Aguiar; U. Bohn; F. Molano; J. Almenarez; I. García; J.C. Díaz-Chi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 113 KB

6098 POSTER CRAFT Trial-Result From Mult

6098 POSTER CRAFT Trial-Result From Multicenter Phase II Study of Modified FOLFOX7 (Combination Chemotherapy of Infusional 5-FU/l-Leucovorin and Intermittent Oxaliplatin) With Bevacizumab in the First-line Therapy of Colorectal Cancer

✍ Ishibashi, K.; Koda, K.; Oshiro, M.; Matsuoka, H.; Baba, H.; Ishida, H.; Katoh, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Adjuvant chemotherapy with oxaliplatin,

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB